BioCentury | Nov 11, 2013
Clinical News

TPM/oxymorphone patch: Phase I data

...trial showed that all 12 healthy volunteers who received the first application of Phosphagenics' 3-day TPM/oxymorphone patch...
...extended-release opioid analgesic formulated using TIMERx delivery technology. Phosphagenics Ltd. (ASX:POH; OTCQX:PPGNY), Melbourne, Australia Product: TPM/oxymorphone patch...
BioCentury | Apr 15, 2013
Clinical News

TPM/Oxymorphone patch: Phase I data

...An Australian Phase I trial showed that a single patch application of Phosphagenics' TPM/oxymorphone patch "successfully" delivered...
...The company could not be reached for details. Phosphagenics Ltd. (ASX:POH; OTCQX:PPGNY), Melbourne, Australia Product: TPM/Oxymorphone patch...
Items per page:
1 - 2 of 2